PDE4A and serum lipopolysaccharide activity: Both compounds exhibit a moderate activity in LPS-induced endotoxemia model and CIA, compared to that of a potent pan-PDE4 inhibitor – rolipram, which most strongly inhibited CIA progression and TNF-α plasma levels in LPS-induced endotoxemia.